AZNAstraZeneca PLC
$159.19+5.4% 1Y
$159.19
$145.5452 weeks$208.62
AZN as reported
- Operating margin
- 26%
Operating margin · trailing twelve months to Q2 2025
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Gross margin | 83% | n/a | Q2 2025 |
| Operating margin | 26% | n/a | Q2 2025 |
| Net margin | 19% | n/a | Q2 2025 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
AstraZeneca PLC (AZN) · Revenue and profitRevenue and profitAstraZeneca PLC (AZN)
RevenueNet incomeTrailing twelve months
Powered byryufin.com
Drug Manufacturers, General
Ranks #5 of 7 by RyuScore